Stem cell biologists sure play a mean pinball dhruv Sareen & Clive n Svendsen

Mouse fibroblasts are reprogrammed to functional neurons by expression of a few transcription factors.
Developmental biologists have traditionally considered lineage commitment and differentiation to be unidirectional and irreversible processes enforced by stable epigenetic patterns. But recent advances in stem cell biology have shown that, at least under certain conditions, mature adult cells are capable of changing cell type in response to ectopic cues. In the latest example, Vierbuchen et al. 1 report in Nature that cells from the mesodermal lineage (fibroblasts) can be switched to an ectodermal lineage (neurons) using a simple cocktail of transcription factors. These results promise to open new avenues for the regeneration of neural tissues and provide further evidence that lineage reprogramming might be harnessed to create a variety of desired cell types for regenerative medicine and drug discovery.
The idea that each somatic cell has the potential to regenerate an entire organism arose from pioneering studies of cloning, first in amphibians and then in mammals. The recent discovery that ectopic expression of Oct4, Sox2, Klf4 and c-Myc can push terminally differentiated cells back in time to a pluripotent state 2,3 has both confirmed this basic idea and changed the way that biologists think about cellular differentiation. In particular, the simplicity of creating induced pluripotent stem (iPS) cells with a small number of transcription factors has led to a reassessment of the plasticity of somatic cells.
As iPS cells can be differentiated to virtually any tissue of the body, they represent a new source of autologous tissue for cell therapy. An alternative approach to the generation of desired cell types is lineage reprogramming, in which one type of mature, differentiated cell is transformed into another. Important insights into this process came from studies showing that exocrine pancreatic acinar cells were reprogrammed to endocrine beta-islet cells using the transcription factors Pdx1, Ngn3 and MafA 4 , that expression of Atoh1 in nonsensory cochlear cells generated functional auditory hair cells 5 and that B lymphocytes could be converted to macrophages using C/EBP genes 6 . In neural reprogramming, expression of the neuralspecific transcription factors Pax6, Ngn2 and Ascl1 (also Mash1) switched astroglial cells to neurons 7 , and expression of Nurr1, Ngn2 and Mash1 generated dopaminergic neurons from restricted neural progenitors 8 .
Vierbuchen et al. 1 began by compiling a list of 19 important transcription factors known to co-regulate the neurogenic program during development. They infected embryonic and 3-day-old tail-tip fibroblasts isolated from mice expressing green fluorescent protein (GFP) under the control of the neural Tau gene with viruses expressing all 19 factors and their permutations. By studying different combinations they found that only five genes-Ascl1, Brn2/4, Myt1l, Zic1 and Olig2-were capable of repatterning fibroblasts to GFP-expressing neurons, termed induced neuronal (iN) cells. The only gene absolutely required was Ascl1. However, Brn2 and Myt1l or Zic1 were needed to increase transformation efficiency, maturation and generation of more complex neuronal phenotypes. Similarly, the efficiency of reprogramming to iPS cells can be improved by increasing the number of exogenous transcription factors.
Vierbuchen et al. 1 found that neurotransmitters elicited responses from the iN cells that are characteristic of excitatory glutamatergic neurons and inhibitory GABAergic neurons. However, more restricted dopaminergic, cholinergic and serotonergic projection neurons of the central nervous system were not obtained. Importantly, purified iN cells were capable of firing repetitive action potentials and formed functional synapses. Analysis of the synaptic activity showed a preponderance of excitatory cortical neurons. The majority of the new neural cells were born early and over time developed elaborate fibers and specialized electrophysiology. Nonetheless, it remains to be determined whether iN cells made a complete and stable phenotypic switch or whether a partially intact fibroblast epigenetic pattern survived after incomplete neural reprogramming.
One possible shortcoming of this study is that the authors used only embryonic and neonatal tail tip fibroblasts as the starting material. Although there was little evidence of neuronal production from these tissues, neural crest derivatives that migrate from the neural tube into peripheral tissues during development are known to permeate many skin structures 9 . Indeed, they have been shown to persist until adult development as multipotent skin-derived precursors 10 . To determine whether rare neural crest cells rather than fibroblasts responded to Ascl1 and the other reprogramming factors, it would be useful to perform clonal studies and to evaluate fibroblasts for an assortment of neural crest markers. Interestingly, Sox10, an early neural crest marker, was expressed in tail-tip fibroblasts. Nevertheless, the authors did not rule out the possibility that the iN cells could represent dorsal root ganglion or sympathetic neurons of the peripheral nervous system, evidenced by expression of peripherin in some iN cells. If true, this would further suggest the possibility of a neural crest derivative contaminating the primary fibroblast cultures from which the iN cells were generated.
If iN cells do arise from differentiated fibroblasts, it will be important to work out the underlying mechanisms of reprogramming. Both Vierbuchen et al. 1 and the authors of a recent commentary 11 suggest that there may have been a direct transformation from the mesodermal to the ectodermal lineage. Alternatively, it is possible that Ascl1 and the other transcription factors pushed the cells back to a transient primitive (but not pluripotent) state before they differentiated down a different lineage. It seems unlikely that a fully differentiated fibroblast switched fate directly to a fully differentiated neuron. Rather, the fibroblast may have first transitioned back to a neural progenitor state. Vierbuchen et al. 1 did not examine the role of cell division in the reprogramming process. Does the fibroblast have to divide in the presence of Ascl1 before acquiring a neural fate? This may allow it to 'reset' crucial expression profiles to a more primitive state on which other exogenous transcription factors would act. Examining neural progenitor markers such as Pax6 and Tbr2 and inhibiting proliferation during reprogramming would help address these issues. The basis of this model is that reprogramming from one cell fate to another requires a dedifferentiation step back to a more primitive state followed by a new path of differentiation. A zygote ('ball') is formed after a sperm enters the egg (bottom right). Totipotent stem cells are produced from the first few divisions of the fertilized egg and become either embryonic or extraembryonic cell types. As development progresses in the 'ball launch lane', embryonic stem cells emerge in the inner cell mass of the blastocyst. The embryonic stem cell expresses endogenous transcription factors ('bumpers') responsible for self-renewal and maintenance of pluripotency. As it moves forward, its developmental potential becomes increasingly restricted. Differentiation into one of the three major dermal lineages is influenced by the developmental guidance cues and epigenetic determinants ('edges') that the cell encounters. Endogenous transcription factors (bumpers) or exogenous transcription factors ('flippers') can drive differentiation forward or, in some cases, flip the cell upward to a less differentiated state (dotted red arrows). A terminally differentiated cell (brown) falling through 'out lanes' can be forced back to pluripotency through 'return lanes' to make iPS cells by overexpression of master regulators (bottom orange flippers) such as Oct4 and Sox2. The expression of other, less powerful transcription factors (smaller flippers) can only tap the cell within a small radius or across an epigenetic edge to another lineage via a transient more primitive state. in an alternative model, a differentiated cell can be pushed directly sideways to another cell type (transdifferentiation) without being flipped to a less differentiated state.
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blasts without going through a pluripotent stage would have the advantage of circumventing tumorigenicity concerns associated with iPS cells. For most clinical applications, however, it would be necessary to be able to expand the cells, as large numbers of cells are typically required for transplantation. Additional work is needed to determine whether the approach of Vierbuchen et al. 1 can be modified to produce expandable neural progenitor cells.
Whatever the future holds for this fascinating and fast-moving field, it is apparent that stem cell biologists, in the words of The Who's "Pinball Wizard", sure play a mean pinball.
verted to an ectodermal neuronal fate with the Ascl1, Brn2 and Myt1l flippers (blue). For simplicity, we illustrate only two other examples of reprogramming: iPS cells and the intra-lineage conversion of pancreatic endocrine to exocrine cells 4 .
In the future it will be of great interest to assess how this model compares to the alternative view that a cell can move laterally on the pinball machine (or through a tunnel in Waddington's model), thus converting directly to a new lineage without passing through a more primitive state. This will be a fundamental principle to understand as the field moves forward.
It will also be important to evaluate the implications of the present study for cell therapy for diseases of the brain. Intralineage in vivo fate switching within the pancreas or the ear may have immediate impact for diseases like type 1 diabetes or hearing loss. Any newly generated pancreatic beta cells or auditory hair cells would be in a suitable location. However, switching fibroblasts to neurons in vivo would be unrewarding as any new neurons produced would not be in their nervous system niche and would therefore be functionally ineffective. On the other hand, in vitro-generated neurons or neural progenitor cells may be useful in transplantation-based therapies, and the possibility of generating these cells from patient fibroTo illustrate the concept of lineage reprogramming via a transient primitive state, we have developed a model based on the metaphor of a pinball machine (Fig. 1) . In the classic model of C.H. Waddington, a cell moving toward terminal differentiation is represented as a ball rolling down along branching valleys of an epigenetic landscape. In our more interactive model, development of a cell ('ball') begins at the zygote stage and progresses through the blastocyst stage in the 'ball launch lane' (bottom right). As cells move down from the top of the panel, they differentiate into the three germ-cell lineages. A cell is driven to ectoderm, mesoderm or endoderm depending on what cues-'bumpers' or 'flippers'-it strikes. Bumpers represent endogenous transcription factors, whereas flippers represent ectopically expressed transcription factors. The latter can push the cell across epigenetic 'edges' to more primitive stages higher up on the panel or all the way to pluripotency (iPS cells) in the ball launch lane (as shown by the pinball wizard, Shinya Yamanaka 2,3 ) as well as down specific differentiation pathways. Some master-regulator transcription factors, such as Oct4, can propel the cell a long distance toward pluripotency, whereas lineage-specific transcription factors can only tap it within a single lineage.
In the new work by Vierbuchen et al. 1 , putative mesodermal fibroblasts were conMany animal studies have shown the therapeutic potential of using small interfering RnAs (siRnAs) to reduce expression of target genes. Although clinical trials with siRnA are underway for a range of diseases 1 , it has not yet been demonstrated that delivery of siRnA can trigger RnA interference (RnAi) in humans. For instance, in a clinical trial of intravitreal siRnA for the treatment of blinding choroidal neovascularization, the contribution of non-RnAi mechanisms to the decrease in vascularization could not be eliminated 2 .
now, Davis et al. 3 report in Nature that siRnA engages the human RnAi machinery to reduce expression of the M2 subunit of ribonucleotide reductase at both the mRnA and protein levels. The study, which is part of a phase 1 clinical trial of systemic siRnA treatment for patients with solid cancers, involved examining biopsies from just three melanoma patients who had received intravenous infusions of siRnA delivered using synthetic nanoparticles.
The nanoparticles (~70-nm diameter) were stabilized by adamantane (AD)-terminated polyethylene glycol (PEG) complexed with a cyclodextrinbased polymer (CDP). inclusion of the human transferrin (TF) protein on the exposed ends of some of the PEG molecules targeted the nanoparticles to cancer cells expressing the TF receptor.
The authors use 5-nm gold particles to detect the nanoparticles in tumor cells, demonstrating what they believe is the first demonstration of dose-dependent accumulation of systemically delivered targeted nanoparticles in human tumors.
Characterization of the mRnA cleavage products using a modified 5´-RnAligand-mediated 'Rapid Amplification of cDnA Ends' method provided mechanistic evidence that the specific siRnAs engaged the RnA interference apparatus. Details of the efficacy of the approach in causing tumor regression have yet to be reported. Peter Hare
